InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Suri Rajeev, Director. Director active across 2 companies, notably STRYKER CORP. In total, 10 filings have been published. History available since 5 May 2021. The latest transaction was disclosed on 8 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
10 of 10 declarations
Rajeev Suri is a Director at Stryker Corp. In this role, he participates in the strategic direction of the company and important decision-making. His expertise in the medical sector is valuable to the board.